Intervention to Reduce HIV Related Stigma Among Pregnant and Postpartum Women
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Jul 7, 2025
Trial Information
Current as of July 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
HIV-related stigma is a significant barrier to engagement in HIV care and adherence to antiretroviral therapy (ART), contributing to the ongoing global HIV epidemic. Stigma is a pervasive social experience in which people with marginalized attributes or identities are seen as having low social value and experience prejudice and discrimination. Globally, HIV-related stigma affects women more than men, and HIV-positive childbearing women experience even more intense stigma. In low-resource societies, pregnant women are often the first family members to receive HIV testing, a mandatory test du...
Gender
FEMALE
Eligibility criteria
- Inclusion criteria:
- • Diagnosed with HIV
- • Between 24-36 weeks gestation at enrollment
- • Willing to participate during the postpartum period
- Recruitment process:
- • Approached during a prenatal visit by a nurse/midwife
- • Interested women will be connected with a trained research assistant (RA)
- • RA will explain the study to potential participants
- Exclusion criteria:
- • Critically ill and hospitalized pregnant WLWH
- • Pregnant WLWH not planning to live in the region for at least 6 months after childbirth
- • Pregnant WLWH under 13 years old, under parental supervision, and attending mandatory school
- Eligibility of healthcare providers:
- • All providers at the four sites invited to a session at their site
- • Providers eligible if they have worked with WLWH or pregnant/postpartum women for at least 2 months
- • Providers who do not consent to be interviewed will not be included
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Accra, , Ghana
Patients applied
Trial Officials
Jerry J Ouner, PhD, RN, MS
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported